Literature DB >> 23917087

Inhibitors of switch kinase 'spleen tyrosine kinase' in inflammation and immune-mediated disorders: a review.

Maninder Kaur1, Manjinder Singh, Om Silakari.   

Abstract

Spleen tyrosine kinase (Syk), a member of Syk family of non-receptor protein tyrosine kinases plays a significant role in the immune cell signaling in B cells, mast cells, macrophages and neutrophils. Anomalous regulation of this kinase can lead to different allergic disorders and antibody-mediated autoimmune diseases such as rheumatoid arthritis, asthma, psoriasis and allergic rhinitis. Being involved in the growth and survive mechanism of B cells, its inhibition can be beneficial in B-cell lymphoma. Thus, Syk can be sited as a therapeutically relevant target for various allergic and autoimmune disorders. This review article describes the structure of Syk and its role in B-cell signaling. In addition to this, data regarding small molecule inhibitors of Syk has also been reviewed from different papers and patents published.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Asthma; Autoimmune diseases; B-Cell lymphoma; Inflammation; Psoriasis; Spleen tyrosine kinase

Mesh:

Substances:

Year:  2013        PMID: 23917087     DOI: 10.1016/j.ejmech.2013.04.070

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  20 in total

1.  3D-QSAR-Based Pharmacophore Modeling, Virtual Screening, and Molecular Dynamics Simulations for the Identification of Spleen Tyrosine Kinase Inhibitors.

Authors:  Vikas Kumar; Shraddha Parate; Amir Zeb; Pooja Singh; Gihwan Lee; Tae Sung Jung; Keun Woo Lee; Min Woo Ha
Journal:  Front Cell Infect Microbiol       Date:  2022-06-30       Impact factor: 6.073

2.  Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials.

Authors:  Sumit Kunwar; Ashok Raj Devkota; Dipesh K C Ghimire
Journal:  Rheumatol Int       Date:  2016-04-25       Impact factor: 2.631

Review 3.  Getting Syk: spleen tyrosine kinase as a therapeutic target.

Authors:  Robert L Geahlen
Journal:  Trends Pharmacol Sci       Date:  2014-06-26       Impact factor: 14.819

4.  New and Emerging Therapies for Pediatric Atopic Dermatitis.

Authors:  Henry L Nguyen; Katelyn R Anderson; Megha M Tollefson
Journal:  Paediatr Drugs       Date:  2019-08       Impact factor: 3.930

Review 5.  Functional roles of Syk in macrophage-mediated inflammatory responses.

Authors:  Young-Su Yi; Young-Jin Son; Chongsuk Ryou; Gi-Ho Sung; Jong-Hoon Kim; Jae Youl Cho
Journal:  Mediators Inflamm       Date:  2014-06-18       Impact factor: 4.711

6.  Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.

Authors:  Leyre Navarro-Núñez; Alice Y Pollitt; Kate Lowe; Arusa Latif; Gerard B Nash; Steve P Watson
Journal:  Thromb Haemost       Date:  2015-02-19       Impact factor: 5.249

7.  In vitro and in vivo anti-inflammatory activities of Korean Red Ginseng-derived components.

Authors:  Kwang-Soo Baek; Young-Su Yi; Young-Jin Son; Sulgi Yoo; Nak Yoon Sung; Yong Kim; Sungyoul Hong; Adithan Aravinthan; Jong-Hoon Kim; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2016-08-24       Impact factor: 6.060

Review 8.  Role of inflammasomes in inflammatory autoimmune rheumatic diseases.

Authors:  Young-Su Yi
Journal:  Korean J Physiol Pharmacol       Date:  2017-12-22       Impact factor: 2.016

9.  Syk inhibitors interfere with erythrocyte membrane modification during P falciparum growth and suppress parasite egress.

Authors:  Antonella Pantaleo; Kristina R Kesely; Maria Carmina Pau; Ioannis Tsamesidis; Evelin Schwarzer; Oleksii A Skorokhod; Huynh D Chien; Marta Ponzi; Lucia Bertuccini; Philip S Low; Francesco M Turrini
Journal:  Blood       Date:  2017-06-20       Impact factor: 22.113

Review 10.  Functional Role of Milk Fat Globule-Epidermal Growth Factor VIII in Macrophage-Mediated Inflammatory Responses and Inflammatory/Autoimmune Diseases.

Authors:  Young-Su Yi
Journal:  Mediators Inflamm       Date:  2016-06-27       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.